Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma	esophageal adenocarcinoma	Recruiting	Phase 2	2026-10-05		NCT06044311

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Melissa Lumish	2

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center	Cleveland	United States	11

Clinical trials